Txp Neph @WUNephrology Dir. Kidney Txp @stlouisva co-chair KDWG @clingenresource. AE @KidneyMed. Rsrch #complement #genetics #TMA #AMD #Preeclampsia RT#endorse
Missouri, USA
Joined March 2019
- Tweets8.9K
- Following798
- Followers3.5K
- Likes27.9K
Pinned Tweet
Was thrilled to receive this letter about one of my transplant pts who made a donation to the hospital in my name.
As physicians, the trust & well-being of our pts matters most!!
This beautiful gesture tells me I am doing it right. Feeling blessed & happy😊 @WUNephrology
Anuja Java, MD (she/her) retweeted
📍 Happening now at @ASNKidney KidneyWeek in Denver!
Join us for the ASN OncoNephrology Program for a day of cutting-edge science, emerging cancer therapies, and practical insights.
Are your ready? 🫘
@onconeph @rc_oncneph @SheronLatcha @ShrutiGkidney @PaulHannaMD @hhashmi87
Anuja Java, MD (she/her) retweeted
Don’t miss @anuja_java's presentation and panel at #KidneyWk 2026 Early Program!
Explore the full @WashUNephrology calendar: nephrology.wustl.edu/washu-n…
Anuja Java, MD (she/her) retweeted
Denver, here we come! Check out our 2026 ASN #KidneyWk @WashUNephrology calendar of presentations, posters, and more!
nephrology.wustl.edu/washu-n…
Anuja Java, MD (she/her) retweeted
How much kidney function is enough for the right dose?
This session by @PaulHannaMD and Thomas Nolin looks at individualising GFR assessment and multidisciplinary dose adjustment of anticancer therapies in CKD and ESKD.
@rc_oncneph @onconeph @SheronLatcha @ShrutiGkidney
Anuja Java, MD (she/her) retweeted
🩸Thrombotic Microangiopathy in Patients with Cancer 🩸
Cancer associated TMA can be complex, especially when complement activation is involved.
This session by @anuja_java will explore the role of complement regulation and inhibition in these patients.
@rc_oncneph @onconeph
Anuja Java, MD (she/her) retweeted
Our next session?
🩺Case Based Debates in Onconephrology ➡️ To Transplant or Not to Transplant in patients with cancers ?
Discussants : Nadia Al Haddad, @hhashmi87 @anuja_java @nymurakami @itunuowoyemi
Register 🔗: asn-online.org/education/kid…
@rc_oncneph @onconeph @SheronLatcha
Anuja Java, MD (she/her) retweeted
🦀🫘👩🏻⚕️Kidney Transplant Onconephrology
How do we approach cancer treatment in KTRs?
Dr Murakami @nymurakami discusses immunotherapy, engineered cellular therapies and management of PTLDs
Register 🔗 : asn-online.org/education/kid…
@onconeph @SheronLatcha @rc_oncneph @ShrutiGkidney
Anuja Java, MD (she/her) retweeted
✨Session 4: AKI and Electrolyte Disturbances in Cancer and Novel Targeted Therapies
Cancer therapies continue to evolve, and so do the kidney complications we see with them.
🎙️ : @ZiolkowskiSusan
@onconeph @SheronLatcha @MaulinPatelDO
Register : asn-online.org/education/kid…
Anuja Java, MD (she/her) retweeted
Next off, we discuss Novel Radioligand Therapies and Nephrotoxicity
This session by @rc_oncneph will focus on these newer therapies and an important question for nephrologists: what do we need to know about their renal effects?
@onconeph @SheronLatcha @ShrutiGkidney
Anuja Java, MD (she/her) retweeted
Explore Genetics in Kidney Care
The Genetics in Kidney Health Summit Recordings Showcase brings together established approaches, emerging research, and patient stories.
Watch on demand: vimeo.com/showcase/12432086
Anuja Java, MD (she/her) retweeted
Update on Paraproteinemia and Kidney Pathologies: Monoclonal vs. Monotypic
This session by Lihong Bu will look at monoclonal vs. monotypic patterns and the renal pathologies we need to recognise.
@onconeph @SheronLatcha @rc_oncneph @ShrutiGkidney
Anuja Java, MD (she/her) retweeted
Here’s the ASN Onconephrology Program at #KidneyWeek 2026 in Denver.
A full day covering new therapies, kidney complications of cancer treatment, transplant, pathology, immunotherapy, & case-based discussions.
Hope to see many of you there!
@onconeph @rc_oncneph @SheronLatcha
Anuja Java, MD (she/her) retweeted
Keep growing your clinical knowledge after #aHUS24Sept. 📈Join the Society of Critical Care Medicine (@SCCM) this Friday for a webcast on accelerating diagnosis and improving outcomes for atypical HUS & #TMA. 🗓️25 Sept 2026⏰ 10:00 - 11:00 AM CT #aHUS #CriticalCare #MedEd
Anuja Java, MD (she/her) retweeted
Keep growing your clinical knowledge after #aHUS24Sept. 📈Join the Society of Critical Care Medicine (@SCCM ) TODAY for a webcast on accelerating diagnosis and improving outcomes for atypical HUS & #TMA. 🗓️25 Sept 2026⏰ 10:00 - 11:00 AM CT #aHUS #CriticalCare #MedEd
Today, on #aHUSAwarenessDay, we recognize the patients and families living with a rare and often unpredictable disease, and the community working alongside them!!
Every story adds to what we know. Every question still unanswered gives us a reason to keep going.
Anuja Java, MD (she/her) retweeted
🔬 Diagnosing #aHUS remains a clinical challenge. Clinicians & researchers: Help others navigate complex aHUS diagnosis & care by sharing your work/insights with colleagues w/#aHUS24Sept. An expert review from @anuja_java on this complex #raredisease:
pmc.ncbi.nlm.nih.gov/article…
Anuja Java, MD (she/her) retweeted
👏Check out recent publications @WashUNephrology by @Myasirbaloch, @anuja_java, @HumphreysLab, Chenjian Gu, and Yili Fang (Maggie Chen Lab).
nephrology.wustl.edu/washu-n…
Anuja Java, MD (she/her) retweeted
ISN e-symposium today on genetic and clinical implications in aHUS management @anuja_java
@ISNkidneycare
@ISNeducation
#ThisIsISN
#ISNWebinar
Anuja Java, MD (she/her) retweeted
We are hiring a nephrologist at the Durham VA in North Carolina. I have been practicing here for 19 years and would love to have you join us in a wondefrful academic environment. See the job description attached or reach out to me if you are interested
usajobs.gov/job/885314900
Congrats @ShrutiGkidney & @rc_oncneph for an engaging symposium! There is still so much to understand about complement in cancer, which makes the road ahead all the more exciting. Thank you for having me! Fantastic talks by @aishaikh @HerrmannMd @PepaSolerR @onconeph
🧵 Cancer & Complementology with Anuja Java
A fascinating look at how complement can be both friend and foe in cancer, and why context matters so much.
@anuja_java @rc_oncneph @ShrutiGkidney @harvardmed @DanaFarber
